• No results found

drug release studies

DEVELOPMENT OF ZOLMITRIPTAN MOUTH DISSOLVING FILMS: FORMULATION VARIABLES, MECHANICAL PROPERTIES, AND IN VITRO DRUG RELEASE STUDIES

DEVELOPMENT OF ZOLMITRIPTAN MOUTH DISSOLVING FILMS: FORMULATION VARIABLES, MECHANICAL PROPERTIES, AND IN VITRO DRUG RELEASE STUDIES

... and drug release properties were ...vitro, drug release studies indicate that higher film thickness and polymer viscosities delayed the MDF disintegration and, in turn, the ZOL ...ZOL ...

7

OCTENYL SUCCINATE CASSAVA STARCH AS AN EXCIPIENT FOR CONTROLLED RELEASE OF THEOPHYLLINE: MICROWAVE ASSISTED SYNTHESIS, CHARACTERIZATION AND IN VITRO DRUG RELEASE STUDIES

OCTENYL SUCCINATE CASSAVA STARCH AS AN EXCIPIENT FOR CONTROLLED RELEASE OF THEOPHYLLINE: MICROWAVE ASSISTED SYNTHESIS, CHARACTERIZATION AND IN VITRO DRUG RELEASE STUDIES

... controlled release of theophylline from the OSA starch matrix, especially at the higher DS of ...vitro drug release studies: To understand the dissolution behaviour of theophylline from the ...

12

DEVELOPMENT AND IN VITRO DRUG RELEASE STUDIES OF SATRANIDAZOLE CAPSULES FOR COLON SPECIFIC DRUG DELIVERY

DEVELOPMENT AND IN VITRO DRUG RELEASE STUDIES OF SATRANIDAZOLE CAPSULES FOR COLON SPECIFIC DRUG DELIVERY

... targeting drug delivery systems have gained importance for the systemic delivery of protein and peptide ...intestine. Drug targeting to colon is also useful when a delay in drug absorption is desired ...

9

Oral solid self-nanoemulsifying drug delivery systems of candesartan citexetil: formulation, characterization and in vitro drug release studies

Oral solid self-nanoemulsifying drug delivery systems of candesartan citexetil: formulation, characterization and in vitro drug release studies

... model drug (CC) solubility, wettability, dissolution and stability in the desired fashion than did the conventional dosage ...best drug release, prov- ing that delivering the drug in a highly ...

17

Oral nanoemulsions of candesartan cilexetil: formulation, characterization and in vitro drug release studies

Oral nanoemulsions of candesartan cilexetil: formulation, characterization and in vitro drug release studies

... Candesartan cilexetil (CC) is a selective, reversible and competitive angiotensin II type-1 (AT1) receptor blocker belonging to class II in biopharmaceutical drug classifi- cation system (BCS) with absolute ...

16

COMPARATIVE IN VITRO DRUG RELEASE STUDIES OF GLIMEPIRIDE SOLID DISPERSIONS & METFORMIN MICROCAPSULES

COMPARATIVE IN VITRO DRUG RELEASE STUDIES OF GLIMEPIRIDE SOLID DISPERSIONS & METFORMIN MICROCAPSULES

... Sustain release formulation suitable for Metformin hydrochloride, therefore, should be a micro- encapsulation dosage form, which releases the drug slowly in the stomach for gradual absorption in the ...

7

IN VITRO EVALUATION OF EFFECT OF HYDROALCOHOLIC MEDIA ON DRUG RELEASE FROM SUSTAINED RELEASE FORMULATION

IN VITRO EVALUATION OF EFFECT OF HYDROALCOHOLIC MEDIA ON DRUG RELEASE FROM SUSTAINED RELEASE FORMULATION

... conduct drug release studies from marketed formulations of Metformin HCl as well as Diclofenac Na in the proposed new, chemically defined, hydroalcoholic media containing 24 ml ...in drug ...

8

In Vitro Studies of NIPAAM MAA VP Copolymer Coated Magnetic Nanoparticles for Controlled Anticancer  Drug Release*

In Vitro Studies of NIPAAM MAA VP Copolymer Coated Magnetic Nanoparticles for Controlled Anticancer Drug Release*

... For drug-loading and drug release studies, DOX was used as a model drug. In brief, 60 mg of freeze-dried PNIPAAm-MAA-VP, MNPs 5 mg and 12 mg of DOX were dispersed in phosphate buffer ...

8

Influence of cholesterol on liposome stability and on in vitro drug release

Influence of cholesterol on liposome stability and on in vitro drug release

... reduce drug incorporation efficiency [ ...stability studies, the article will focus the attention on release of two drugs with different physicochemical characteristics that loaded into the two ...

31

 STUDIES ON COMPRESSION AND DRUG RELEASE CHARACTERISTICS OF XANTHIUM GUM PELLETS OF DIFFERENT COMPOSITIONS

 STUDIES ON COMPRESSION AND DRUG RELEASE CHARACTERISTICS OF XANTHIUM GUM PELLETS OF DIFFERENT COMPOSITIONS

... hardness, drug content and drug release ...and Drug entrapment of optimized formulations after stability studies were shown in table 9, Dissolution study of optimized formulations after ...

8

RELEASE OF DEFENDANT/OFFENDER DRUG TEST INFORMATION

RELEASE OF DEFENDANT/OFFENDER DRUG TEST INFORMATION

... to release to an offender his/her own drug test results and levels interpretations, provided that the offender submits a signed written request to the supervising ...the drug test results within one ...

6

GASTRO-RETENTIVE DRUG DELIVERY SYSTEM FOR PROLONG DRUG RELEASE: A BLANKET REVIEW

GASTRO-RETENTIVE DRUG DELIVERY SYSTEM FOR PROLONG DRUG RELEASE: A BLANKET REVIEW

... a drug is essentially a vital phenomenon which refers to the extent and rate at which the active drug or metabolite enters the systemic circulation and reaching the site of action ...the drug reaches ...

5

A general model of coupled drug release and tissue absorption for drug delivery devices

A general model of coupled drug release and tissue absorption for drug delivery devices

... Local drug delivery devices (DDD) are now common in clinical ...include drug-eluting stents [1], therapeutic contact lenses [2], transdermal patches [3], and most recently drug-eluting orthopaedic ...

10

IMPROVED RELEASE ORAL DRUG DELIVERY OF METAXALONE

IMPROVED RELEASE ORAL DRUG DELIVERY OF METAXALONE

... Characterization of microemulsion: The optimized microemulsions were subjected for physicochemical characterization. The physicochemical characteristics of microemulsion are shown in Table 2. The average globule size of ...

8

INTERCALATION OF ITRACONAZOLE INTO MONTMORILLONITE: EFFECT ON RELEASE OF DRUG

INTERCALATION OF ITRACONAZOLE INTO MONTMORILLONITE: EFFECT ON RELEASE OF DRUG

... Itraconazole (ICZ) is a broad spectrum antifungal agent belonging to azole class of antifungals. [1,2] It is used for the fungal infection of fingernails and is used to treat fungal infection of toe nails. It is reported ...

5

Polyurethane membrane with porous surface for controlled drug release in drug eluting stent

Polyurethane membrane with porous surface for controlled drug release in drug eluting stent

... PTX (50 mg) was added into 10 mL of PU solution con- taining various amount of PEG. PTX loaded porous PU membrane was fabricated by above-mentioned method. To investigate drug release profile, approximately ...

5

MODULATION OF DRUG RELEASE KINETICS OF A HIGHLY WATER SOLUBLE DRUG FROM HYDROPHILICMATRICES

MODULATION OF DRUG RELEASE KINETICS OF A HIGHLY WATER SOLUBLE DRUG FROM HYDROPHILICMATRICES

... the drug release from ...burst release from a hydroxypropylmethylcellulose (methocel) matrix formulation containing venlafaxine ...accelerating release rates and poor stability, its use in ...

11

A REVIEW ON SUSTAINED RELEASE DRUG DELIVERY SYSTEM

A REVIEW ON SUSTAINED RELEASE DRUG DELIVERY SYSTEM

... tovarious drug delivery systems preparationconfirms the importance of thesespecialized excipients in ...fluctuating drug plasma levels, lowbioavailability, more frequent doseadministration ...

9

Comparison Between the Effect of Polymers and Surfactants on the Release of Drug from Controlled Release Matrices

Comparison Between the Effect of Polymers and Surfactants on the Release of Drug from Controlled Release Matrices

... In formulation F12, the addition of 16 % Eudragit RS100 and percent reduction of NaCMC from 67% to 50% within the matrices produced increase dissolution in the drug from 61% to 69%. Despite that Eudragit RS100 is ...

7

PREPARATION AND DRUG RELEASE BEHAVIORS OF pH SENSITIVE MICROCAPSULES

PREPARATION AND DRUG RELEASE BEHAVIORS OF pH SENSITIVE MICROCAPSULES

... model drug and Triton X-100 was used as the ...and drug release property of microcapsules were discussed in ...The release behaviors of caffeine in different phosphate-buffered saline (PBS) pH ...

6

Show all 10000 documents...

Related subjects